Psilocybin-Assisted Psychotherapy Trial for Advanced Cancer Patients Launched
A new clinical trial is investigating the feasibility and safety of psilocybin-assisted psychotherapy for advanced cancer patients experiencing depression and anxiety.
Phase III
M.D. Anderson Cancer Center
Status
Initiated
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Why it matters
The launch of this clinical trial for psilocybin-assisted psychotherapy in advanced cancer patients highlights a growing intersection of oncology and mental health treatment. As mental health support becomes increasingly vital in cancer care, the outcomes of this trial could reshape treatment paradigms and influence competitive positioning in the oncology market.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor trial results for efficacy and safety data, as well as regulatory responses to psilocybin therapies in oncology.
Related companies & assets
Assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.